Diabetic retinopathy detection is the process of identifying and diagnosing the growth of abnormal blood vessels and damage in the retina due to high blood sugar from diabetes, using deep learning techniques.
Retinal blood vessel segmentation plays a vital role in the early detection of diabetic retinopathy and glaucoma. While recent deep learning models have achieved great segmentation accuracy, they typically require heavy computational resources, making real-world deployment on edge devices difficult. In this paper, we propose LightVesselNet, an efficient neural network designed for retinal vessel segmentation in a resource-constrained environment. Despite containing only 75K parameters, LightVesselNet performs competitively with much larger models. The network employs a compact encoder decoder architecture enhanced with channel and spatial attention mechanisms, a multi-scale feature aggregation module at the bottleneck, and a subpixel upsampling strategy in the decoder. A dedicated edge residual connection preserves fine vessel detail throughout decoding. Extensive experiments on five publicly available datasets: DRIVE, STARE, CHASEDB1, FIVES, and HRF, yield sensitivity scores of 0.8189, 0.8499, 0.8640, 0.8634, 0.8096, and Dice coefficients of 0.8070, 0.8072, 0.8181, 0.8649, and 0.7686, respectively. LightVesselNet shows improved efficiency (Performance vs Parameter or GFlops) compared to State-of-the-Art models. Cross-dataset evaluation confirms the model's generalisation capability. Overall, LightVesselNet is a strong candidate for deployment in low-resource clinical settings and mobile screening tools.
Vascular structures in the retina contain important information for the detection and analysis of ocular diseases, including age-related macular degeneration, diabetic retinopathy and glaucoma. Commonly used modalities in diagnosis of these diseases are fundus photography, scanning laser ophthalmoscope (SLO) and fluorescein angiography (FA). Typically, retinal vessel segmentation is carried out either manually or interactively, which makes it time consuming and prone to human errors. In this research, we propose a new multi-modal framework for vessel segmentation called ELEMENT (vEsseL sEgmentation using Machine lEarning and coNnecTivity). This framework consists of feature extraction and pixel-based classification using region growing and machine learning. The proposed features capture complementary evidence based on grey level and vessel connectivity properties. The latter information is seamlessly propagated through the pixels at the classification phase. ELEMENT reduces inconsistencies and speeds up the segmentation throughput. We analyze and compare the performance of the proposed approach against state-of-the-art vessel segmentation algorithms in three major groups of experiments, for each of the ocular modalities. Our method produced higher overall performance, with an overall accuracy of 97.40%, compared to 25 of the 26 state-of-the-art approaches, including six works based on deep learning, evaluated on the widely known DRIVE fundus image dataset. In the case of the STARE, CHASE-DB, VAMPIRE FA, IOSTAR SLO and RC-SLO datasets, the proposed framework outperformed all of the state-of-the-art methods with accuracies of 98.27%, 97.78%, 98.34%, 98.04% and 98.35%, respectively.
Diabetic Retinopathy (DR) is one of the leading causes of preventable blindness, yet rural regions often lack the specialists and infrastructure needed for early detection. Although cloud-based deep learning systems offer high accuracy, they face significant challenges in these settings due to high latency, limited bandwidth, and high data transmission costs. To address these challenges, we propose a two-tier edge-cloud cascade on the public APTOS 2019 Blindness Detection dataset. Tier 1 runs a lightweight MobileNetV3-small model on a local clinic device to perform a binary triage between Referable DR (Classes 2-4) and Non-referable DR (Classes 0-1). Tier 2 runs a RETFoundDINOv2 model in the cloud for ordinal severity grading, but only on the subset of images flagged as referable by Tier 1. On a stratified APTOS test split of 733 images, Tier 1 reaches 98.99% sensitivity and 84.37% specificity at a validation-tuned high-sensitivity threshold. The default cascade forwards 49.52% of test images to Tier 2, reducing cloud calls by 50.48% relative to using a cloud-based model for all images. In the deployed 4-class output space (Class 0-1 / Class 2 / Class 3 / Class 4), the cascade obtains 80.49% accuracy and 0.8167 quadratic weighted kappa; the cloud-only baseline obtains 80.76% accuracy and 0.8184 quadratic weighted kappa. On APTOS, the cascade cuts cloud use by about half with a modest drop in grading performance. Index Terms: Diabetic Retinopathy, Edge-Cloud Cascade, MobileNetV3-small, RETFound-DINOv2, Retinal Screening, tele-ophthalmology
Diabetic Retinopathy (DR) is a leading cause of preventable blindness among working-age adults worldwide, yet most automated screening systems are limited to image-level classification and lack clinically structured reporting. We propose Retina-RAG, a low-cost modular framework that jointly performs DR severity grading, macular edema (ME) detection, and report generation. The architecture decouples a high-performance retinal classifier and a parameter-efficient vision-language model (Qwen2.5-VL-7B-Instruct) adapted via Low-Rank Adaptation (LoRA), enabling flexible component integration. A retrieval-augmented generation (RAG) module injects curated ophthalmic knowledge together with structured classifier outputs at inference time to improve diagnostic consistency and reduce hallucinations. Retina-RAG achieves an F1-score of 0.731 for DR grading and 0.948 for ME detection, substantially outperforming zero-shot Qwen (0.096, 0.732) and MMed-RAG (0.541, 0.641) on a retinal disease detection dataset with captions. For report generation, Retina-RAG attains ROUGE-L 0.429 and SBERT similarity 0.884, exceeding all baselines. The full framework operates on a single consumer-grade GPU, demonstrating that clinically structured retinal AI can be achieved with modest computational resources.
Retinal vessel segmentation methods based on standard overlap losses tend to miss thin peripheral vessels because these structures occupy very few pixels and have low contrast against the background. We propose HMS-VesselNet, a hierarchical multi-scale network that processes fundus images across four parallel branches at different resolutions and combines their outputs using learned fusion weights. The training loss combines Dice, binary cross-entropy, and centerline Dice to jointly optimize area overlap and vessel continuity. Hard example mining is applied from epoch 20 onward to concentrate gradient updates on the most difficult training images. Tested on 68 images from DRIVE, STARE, and CHASE_DB1 using 5-fold cross-validation, the model achieves a mean Dice of 88.72 +/- 0.67%, Sensitivity of 90.78 +/- 1.42%, and AUC of 98.25 +/- 0.21%. In leave-one-dataset-out experiments, AUC remains above 95% on each unseen dataset. The largest improvement is in the recall of thin peripheral vessels, which are the structures most frequently missed by standard methods and most critical for early detection of diabetic retinopathy.
Macular Holes, Central serous retinopathy and Diabetic Retinopathy are one of the most widespread maladies of the eyes responsible for either partial or complete vision loss, thus making it clear that early detection of the mentioned defects is detrimental for the well-being of the patient. This study intends to introduce the application of Vision Transformer and Support Vector Machine based hybrid architecture (ViT-SVM) and analyse its performance to classify the optical coherence topography (OCT) Scans with the intention to automate the early detection of these retinal defects.
Diabetic Retinopathy (DR) is a serious microvascular complication of diabetes, and one of the leading causes of vision loss worldwide. Although automated detection and grading, with Deep Learning (DL), can reduce the burden on ophthalmologists, it is constrained by the limited availability of high-quality datasets. Existing repositories often remain geographically narrow, contain limited samples, and exhibit inconsistent annotations or variable image quality; thereby, restricting their clinical reliability. This paper presents a comprehensive review and comparative analysis of fundus image datasets used in the management of DR. The study evaluates their usability across key tasks, including binary classification, severity grading, lesion localization, and multi-disease screening. It also categorizes the datasets by size, accessibility, and annotation type (such as image-level, lesion-level, and multi-disease). Finally, a recently published dataset is presented as a case study to illustrate broader challenges in dataset curation and usage. The review consolidates current knowledge while highlighting persistent gaps such as the lack of standardized lesion-level annotations and longitudinal data. It also outlines recommendations for future dataset development to support clinically reliable and explainable solutions in DR screening.
Hallucinations in medical large language models (LLMs) remain a safety-critical issue, particularly when available evidence is insufficient or conflicting. We study this problem in diabetic retinopathy (DR) decision settings and introduce RETINA-SAFE, an evidence-grounded benchmark aligned with retinal grading records, comprising 12,522 samples. RETINA-SAFE is organized into three evidence-relation tasks: E-Align (evidence-consistent), E-Conflict (evidence-conflicting), and E-Gap (evidence-insufficient). We further propose ECRT (Evidence-Conditioned Risk Triage), a two-stage white-box detection framework: Stage 1 performs Safe/Unsafe risk triage, and Stage 2 refines unsafe cases into contradiction-driven versus evidence-gap risks. ECRT leverages internal representation and logit shifts under CTX/NOCTX conditions, with class-balanced training for robust learning. Under evidence-grouped (not patient-disjoint) splits across multiple backbones, ECRT provides strong Stage-1 risk triage and explicit subtype attribution, improves Stage-1 balanced accuracy by +0.15 to +0.19 over external uncertainty and self-consistency baselines and by +0.02 to +0.07 over the strongest adapted supervised baseline, and consistently exceeds a single-stage white-box ablation on Stage-1 balanced accuracy. These findings support white-box internal signals grounded in retinal evidence as a practical route to interpretable medical LLM risk triage.
Generalizing image classification across domains remains challenging in critical tasks such as fundus image-based diabetic retinopathy (DR) grading and resting-state fMRI seizure onset zone (SOZ) detection. When domains differ in unknown causal factors, achieving cross-domain generalization is difficult, and there is no established methodology to objectively assess such differences without direct metadata or protocol-level information from data collectors, which is typically inaccessible. We first introduce domain conformal bounds (DCB), a theoretical framework to evaluate whether domains diverge in unknown causal factors. Building on this, we propose GenEval, a multimodal Vision Language Models (VLM) approach that combines foundational models (e.g., MedGemma-4B) with human knowledge via Low-Rank Adaptation (LoRA) to bridge causal gaps and enhance single-source domain generalization (SDG). Across eight DR and two SOZ datasets, GenEval achieves superior SDG performance, with average accuracy of 69.2% (DR) and 81% (SOZ), outperforming the strongest baselines by 9.4% and 1.8%, respectively.
Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of preventable blindness among working-age adults. Traditional approaches in the literature focus on standard color fundus photography (CFP) for the detection of these conditions. Nevertheless, recent ultra-widefield imaging (UWF) offers a significantly wider field of view in comparison to CFP. Motivated by this, the present study explores state-of-the-art deep learning (DL) methods and UWF imaging on three clinically relevant tasks: i) image quality assessment for UWF, ii) identification of referable diabetic retinopathy (RDR), and iii) identification of DME. Using the publicly available UWF4DR Challenge dataset, released as part of the MICCAI 2024 conference, we benchmark DL models in the spatial (RGB) and frequency domains, including popular convolutional neural networks (CNNs) as well as recent vision transformers (ViTs) and foundation models. In addition, we explore a final feature-level fusion to increase robustness. Finally, we also analyze the decisions of the DL models using Grad-CAM, increasing the explainability. Our proposal achieves consistently strong performance across all architectures, underscoring the competitiveness of emerging ViTs and foundation models and the promise of feature-level fusion and frequency-domain representations for UWF analysis.